FibroNest

Curated by Signal

Provider of AI-based digital pathology solutions for drug discovery and development

Overview

Provider of AI-based digital pathology solutions for drug discovery and development. It offers a cloud-based image analysis tool that provides the most advanced phenotypic image analysis and a translational platform for the quantification of fibrosis and steatosis for NASH and for other fibrotic conditions in drug discovery and drug development.

Key facts

Founded: 2018
Headquarters: Princeton, United States
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Impathiq
A data informatics platform that allows integration of new apps and programs in EHR
Health TechnologyRaleigh, United States
Aleafiate
Provider of cannabis-derived wellness products to maintain health
Health TechnologyHialeah, United States
NanoDiagnostic Technology
Developer of integrated smartphone-nanosensors-cloud platforms for point-of-care diagnosis
Health TechnologyKannapolis, United States

About FibroNest

What does FibroNest do?

Provider of AI-based digital pathology solutions for drug discovery and development.

Where is FibroNest headquartered?

FibroNest is headquartered in Princeton, United States.

When was FibroNest founded?

FibroNest was founded in 2018.

Which sector is FibroNest in?

FibroNest operates in Health Technology.

Who are FibroNest's competitors?

Companies similar to FibroNest include Impathiq, Aleafiate, and NanoDiagnostic Technology.